3-(tert-Butyl)-4-(2,6-dimethoxy-3,5-dimethylphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole

Catalog No. :
ACERIH453
CAS No. :
2414245-22-8
Molecular Formula :
C21H27O3P
Molecular Weight :
358.42

IUPAC Name:3-(tert-butyl)-4-(2,6-dimethoxy-3,5-dimethylphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole

3-(tert-Butyl)-4-(2,6-dimethoxy-3,5-dimethylphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(tert-Butyl)-4-(2,6-dimethoxy-3,5-dimethylphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole
IUPAC Name3-(tert-butyl)-4-(2,6-dimethoxy-3,5-dimethylphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole
MDL No.-
Molecular FormulaC21H27O3P
Molecular Weight358.42
SMILESCOC1=C(C)C=C(C)C(OC)=C1C1=C2C(=CC=C1)OCP2C(C)(C)C
InChI KeyHEETVIXTAXQITH-UHFFFAOYSA-N
Synonym3-(tert-butyl)-4-(2,6-dimethoxy-3,5-dimethylphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole;ZJ-0128;4-(2,6-Dimethoxy-3,5-dimethylphenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-1,3-benzoxaphosphole
CAS No.2414245-22-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACERIH453 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACERIH453 route product structure diagram
    ACERIH4532414245-22-8
Inquiry

2. ACERIH453 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACERIH453 route product structure diagram
    ACERIH4532414245-22-8
Inquiry

Comments (0)